Core Viewpoint - The company reported strong revenue and profit growth for 2024 and Q1 2025, driven by high-end product sales and improved gross margins, leading to an upward revision of the target price to 130 yuan and a "buy" rating [1][2][4]. Group 1: 2024 Performance - In 2024, the company achieved revenue of 5.25 billion yuan, a year-on-year increase of 21%, and a net profit attributable to shareholders of 625 million yuan, up 46% year-on-year [1]. - Domestic sales reached 3.55 billion yuan, growing 24% year-on-year, with high-end products like 麦富迪 and 弗列加特 seeing significant growth [2]. - The gross margin improved to 45.6%, an increase of 6.4 percentage points year-on-year, reflecting the rising contribution of high-end products and effective brand premium [2]. Group 2: Q1 2025 Performance - In Q1 2025, the company reported revenue of 1.48 billion yuan, a year-on-year increase of 34.8%, and a net profit of 204 million yuan, up 37.7% year-on-year [1]. - Domestic sales are expected to grow over 40%, driven by high sales of 弗列加特 and barf series products [3]. - The gross margin for Q1 2025 was 41.6%, a year-on-year increase of 0.42 percentage points, indicating sustained profitability despite slight fluctuations [3]. Group 3: Profit Forecast and Valuation - The profit forecast for 2025 has been adjusted down to 790 million yuan, a decrease of 6%, while the 2026 forecast remains unchanged at 1.12 billion yuan [4]. - The company is valued at 65.5 times the expected earnings for 2025, reflecting its strong market position and brand barriers [4]. - The target price has been set at 130 yuan, maintaining a "buy" rating based on the company's leading position in the domestic pet food market [4].
乖宝宠物(301498)：Q1盈利超预期 品牌高端化成效显著